4.7 Letter

SARS-CoV-2 omicron variant: Could it be another threat?

Journal

JOURNAL OF MEDICAL VIROLOGY
Volume 94, Issue 4, Pages 1284-1288

Publisher

WILEY
DOI: 10.1002/jmv.27532

Keywords

-

Categories

Funding

  1. National Vaccine Institute, Thailand
  2. Baiya Phytopharm Co., Ltd., Thailand
  3. Second Century Fund(C2F), Chulalongkorn University

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available